Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142259 |
| CAS No | NA |
| Mol.F. | C13H19N3O2 |
| Mol.Wt. | 249.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142260 |
| CAS No | NA |
| Mol.F. | C14H17Br2N3O2 |
| Mol.Wt. | 419.12 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142261 |
| CAS No | NA |
| Mol.F. | C13H18BrN3O2 |
| Mol.Wt. | 328.21 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142262 |
| CAS No | NA |
| Mol.F. | C26H36Br2N4O4 |
| Mol.Wt. | 628.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142263 |
| CAS No | NA |
| Mol.F. | C26H36Br2N4O4 |
| Mol.Wt. | 628.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142264 |
| CAS No | NA |
| Mol.F. | C16H21Br2N3O4 |
| Mol.Wt. | 479.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142265 |
| CAS No | NA |
| Mol.F. | C16H21Br2N3O4 |
| Mol.Wt. | 479.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142266 |
| CAS No | NA |
| Mol.F. | C15H19Br2N3O4 |
| Mol.Wt. | 465.14 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142267 |
| CAS No | NA |
| Mol.F. | C15H19Br2N3O4 |
| Mol.Wt. | 465.14 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142268 |
| CAS No | NA |
| Mol.F. | C16H21Br2N3O4 |
| Mol.Wt. | 479.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142269 |
| CAS No | NA |
| Mol.F. | C11H14N2O2 |
| Mol.Wt. | 206 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142270 |
| CAS No | NA |
| Mol.F. | C7H7N5O3 |
| Mol.Wt. | 209.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142271 |
| CAS No | NA |
| Mol.F. | C23H26N2O4 |
| Mol.Wt. | 394.47 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142272 |
| CAS No | NA |
| Mol.F. | C23H25IN2O4 |
| Mol.Wt. | 520.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142273 |
| CAS No | NA |
| Mol.F. | C24H26I2N2O5 |
| Mol.Wt. | 676.29 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142274 |
| CAS No | NA |
| Mol.F. | C4H9ClN2O |
| Mol.Wt. | 136.58 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |